Date: 2018
Type: Contribution to book
Denouncing trade agreements validating pharmaceutical developers’ term extensions
Lillian CORBIN and Mark PERRY (eds), Free trade agreements : hegemony or harmony, Singapore : Springer, 2018, pp. 139-161
TRIPATHY, Sunita, Denouncing trade agreements validating pharmaceutical developers’ term extensions, in Lillian CORBIN and Mark PERRY (eds), Free trade agreements : hegemony or harmony, Singapore : Springer, 2018, pp. 139-161
- https://hdl.handle.net/1814/60940
Retrieved from Cadmus, EUI Research Repository
Free Trade agreements have had extraordinary effects on the production and use of pharmaceuticals in India. Following the Word Trade Organisation’s Agreement on Trade Related Aspects of Intellectual Property, there has been a plethora of attempts at the level of international trade negotiations to extend the rights of pharmaceutical companies over medicinal compounds. This chapter explores this area’s developments showing how it has been a detrimental development for countries such as India.
Additional information:
First Online: 30 October 2018
Cadmus permanent link: https://hdl.handle.net/1814/60940
Full-text via DOI: 10.1007/978-981-13-3038-4_8
ISBN: 9789811330377; 9789811330384
Version: This book chapter is a revised version of the presentation ‘Innovation Models in the Pharmaceutical Industry’ at the Second Asia-Pacific Workshop on Innovation, IP and Competition at National Law University, New Delhi, INDIA on February 07, 2018 that was later expanded and developed into a working paper entitled ‘Patent Linkage within TRIPS: A Purposive Interpretation’ presented at PatCon 8: The Annual Patent Conference held at University of San Diego School of Law, USA on March 02, 2018.
Files associated with this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||